Fingolimod Accord

ATC：L04AA27

治疗领域：Multiple Sclerosis, Relapsing-Remitting

药理分类：Immunosuppressants;Selective immunosuppressants

修订号：12 · 最新影响 PI 的程序：VR/0000379204

适应症（原文）：Indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult patients and paediatric patients aged 10 years and older: Patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy or Patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more Gadolinium enhancing lesions on brain MRI or a significant increase in T2 lesion load as compared to a previous recent MRI.